Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation

Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation

Objective Patients with nonvalvular atrial fibrillation (AF) and renal disease (RD) who receive anticoagulation therapy appear to be at greater risk of major bleeding (MB) than AF patients without RD. As observed in past studies, anticoagulants are frequently withheld from AF patients with RD due to...

Full description

Bibliographic Details
Main Authors: Manesh R. Patel, W. Frank Peacock, Sally Tamayo, Nicholas Sicignano, Kathleen P. Hopf, Zhong Yuan
Format: Article
Language:English
Published: The Korean Society of Emergency Medicine 2018-03-01
Series:Clinical and Experimental Emergency Medicine
Subjects:
atrial fibrillation
major bleeding
rivaroxaban
renal disease
Online Access:http://www.ceemjournal.org/upload/pdf/ceem-17-216.pdf

Similar Items

Similar Items